{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:30:54Z","timestamp":1788921054022,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.bbr.2005.11.023","type":"journal-article","created":{"date-parts":[[2006,1,5]],"date-time":"2006-01-05T08:25:35Z","timestamp":1136449535000},"page":"318-322","source":"Crossref","is-referenced-by-count":68,"title":["Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice"],"prefix":"10.1016","volume":"168","author":[{"given":"R\u00fabia C.","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane S.","family":"Felisbino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela G.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L\u00facia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson H.","family":"Gabilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2005.11.023_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2005.10.057","article-title":"Involvement of PKA, MAPK\/ERK and CaMKII, but not PKC in the acute antidepressant-like effect of memantine in mice","volume":"395","author":"Almeida","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2005.11.023_bib2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.neuint.2004.03.015","article-title":"Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages","volume":"45","author":"Bender","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbr.2005.11.023_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-004-1900-0","article-title":"Involvement of NO\/cGMP pathway in toluene-induced locomotor hyperactivity in female rats","volume":"176","author":"Chan","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2005.11.023_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0165-0173(00)00018-7","article-title":"Roles of NMDA receptor activity and nitric oxide production in brain development","volume":"32","author":"Contestabile","year":"2000","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.bbr.2005.11.023_bib5","first-page":"3699","article-title":"Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice","volume":"11","author":"da Silva","year":"2000","journal-title":"Neuro Report"},{"key":"10.1016\/j.bbr.2005.11.023_bib6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0005-2728(99)00024-9","article-title":"Guanylate cyclase and the NO\/cGMP signaling pathway","volume":"1411","author":"Denninger","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bbr.2005.11.023_bib7","first-page":"839","article-title":"Acute treatments with GMP produce antidepressant-like effects in mice","volume":"11","author":"Eckeli","year":"2000","journal-title":"Neuro Report"},{"key":"10.1016\/j.bbr.2005.11.023_bib8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bjp.0704569","article-title":"NO as a signalling molecule in the nervous system","volume":"135","author":"Esplugues","year":"2002","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.bbr.2005.11.023_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0014-2999(99)00191-0","article-title":"Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test","volume":"372","author":"Harkin","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2005.11.023_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.euroneuro.2003.08.010","article-title":"Nitric oxide inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test","volume":"14","author":"Harkin","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2005.11.023_bib11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0028-3908(03)00030-3","article-title":"Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors","volume":"44","author":"Harkin","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2005.11.023_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0166-4328(02)00084-0","article-title":"Reduction of cGMP and nitric oxide has antidepressant like effects in the forced swimming test in rats","volume":"134","author":"Heiberg","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2005.11.023_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pbb.2003.12.024","article-title":"Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation","volume":"77","author":"Inan","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2005.11.023_bib14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2165\/00002512-200320060-00005","article-title":"Memantine","volume":"20","author":"Jarvis","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bbr.2005.11.023_bib15","first-page":"587","article-title":"Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain","volume":"53","author":"Karolewicz","year":"2001","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.bbr.2005.11.023_bib16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbr.2005.06.031","article-title":"Effects of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway","volume":"165","author":"Kaster","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2005.11.023_bib17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S1461145705005316","article-title":"Involvement of nitric-oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test","volume":"8","author":"Kaster","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2005.11.023_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00008877-200505000-00004","article-title":"A comparison of the predictive therapeutic and undesired side-effects of the NMDA receptor antagonist, memantine, in mice","volume":"16","author":"Kos","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2005.11.023_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1602\/neurorx.1.1.101","article-title":"Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults","volume":"1","author":"Lipton","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.bbr.2005.11.023_bib20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0773.1993.tb01351.x","article-title":"Potential antidepressive of amantadine, memantine and bifemelane","volume":"72","author":"Moryl","year":"1993","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.bbr.2005.11.023_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well-tolerated N-methyl-d-aspartate (NMDA) receptor antagonist\u2014a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2005.11.023_bib22","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.bbr.2005.11.023_bib23","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Rog\u00f3z","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2005.11.023_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0166-4328(03)00069-X","article-title":"Involvement of NMDA receptors and l-arginine-nitric-oxide pathway in the antidepressant-like effects of zinc in mice","volume":"144","author":"Rosa","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2005.11.023_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressant for the new millennium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2005.11.023_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2004.05.005","article-title":"Dementia of Alzheimer's disease and other neurodegenerative disorders\u2014memantine, a new hope","volume":"51","author":"Sonkusare","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bbr.2005.11.023_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0165-0327(00)00164-6","article-title":"Elevated plasma nitrate levels in depressive states","volume":"63","author":"Suzuki","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbr.2005.11.023_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists of the NMDA receptor complex exhibit antidepressant action","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2005.11.023_bib29","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/j.0953-816X.2004.03327.x","article-title":"Species differences in the localization of cGMP and NO-responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry","volume":"19","author":"Van Staveren","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2005.11.023_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-4328(02)00312-1","article-title":"Antidepressant and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice","volume":"140","author":"Volke","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2005.11.023_bib31","first-page":"653","article-title":"Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice","volume":"54","author":"Volke","year":"2003","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.bbr.2005.11.023_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrd1311","article-title":"Memantine hydrochloride","volume":"3","author":"Witt","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bbr.2005.11.023_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002139900316","article-title":"Antidepressant-like effects of 7-nitroindazole in the forced swimming test in rats","volume":"149","author":"Yildiz","year":"2000","journal-title":"Psychopharmacology"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643280500505X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643280500505X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T02:29:52Z","timestamp":1547864992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016643280500505X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S016643280500505X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2005.11.023","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}